SurGenTec wins FDA nod for hydrophilic synthetic bone graft

OsteoFlo HydroPutty used with Graftgun. [Image courtesy of SurGenTec]SurGenTec announced today that it received FDA 510(k) clearance for its OsteoFlo HydroPutty synthetic bone graft.

OsteoFlo HydroPutty follows the company’s OsteoFlo NanoPutty, which received FDA clearance in 2020. SurGenTec said that, along with clearance, it can report the first implantations of the new graft as well.

The new bone graft offers what the company calls a “significant advancement” in bone graft technology. It features a combination of proprietary hydrophilic carriers designed to absorb fluids like bone marrow aspirate, blood or saline. This formulation turns to putty and offers superior handling characteristics, plus a resorption profile optimized for bone growth.

SurGenTec supplies OsteoFlo HydroPutty in a sterile vial as a dry formulation, accompanied by a mixing spatula. Upon the addition of fluid, the hydrophilic bonds absorb that fluid to form a putty. …

Read more
  • 0

FDA clears SurGenTec synthetic bone graft

SurGenTec announced today that it received FDA 510(k) clearance for its proprietary OsteoFlo NanoPutty quadphasic synthetic bone graft.

Boca Raton, Fla.-based SurGenTec said in a news release that its novel OsteoFlo NanoPutty bone graft features the world’s first and only quadphasic synthetic bone graft particles with nano-surface technology for providing an “optimal resorption profile with unrivaled handling characteristics.”

OsteoFlo requires no mixing, reconstituting or preparation prior to use and is designed to maximize flowable properties when used in minimally invasive surgery. The putty does not harden and can flow through tiny apertures and voids.

The putty comes in two packaging configurations, either a standard syringe or a pre-filled, minimally invasive cartridge that can be used with SurGenTec’s GraftGun single-use bone graft delivery system.

SurGenTec is eyeing a launch for the OsteoFlo NanoPutty in October 20…

Read more
  • 0